Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Alain Bélanger

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Endocrinologie et néphrologie
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
T-3-67
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-656-4141, poste 46442
Télécopieur(s)
+1 418-654-2298
Courriel(s)
alain.belanger@ap.ulaval.ca

Publications récentes (voir toutes les publications de ce chercheur)

Labrie F, Belanger A, Pelletier G, Martel C, Archer DF, Utian WH. Science of intracrinology in postmenopausal women. Menopause (New York, N.Y.) ,  2017. Epub
Labrie F, Martel C, Belanger A, Pelletier G. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. The Journal of steroid biochemistry and molecular biology,  2017. 168: 9-18
Gauthier-Landry L, Belanger A, Barbier O. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution. The Journal of steroid biochemistry and molecular biology,  2015. 145: 187-92
Labrie F, Ke Y, Gonthier R, Belanger A. Reprint of "Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays?". The Journal of steroid biochemistry and molecular biology,  2015. 153: 54-6
Labrie F, Ke Y, Gonthier R, Belanger A. Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays? The Journal of steroid biochemistry and molecular biology,  2015. 149: 89-91
Ekstrom L, Cevenini L, Michelini E, Schulze J, Thorngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane A. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes. European journal of clinical investigation,  2013. 43: 248-55
Grosse L, Paquet S, Caron P, Fazli L, Rennie PS, Belanger A, Barbier O. Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications. Cancer research,  2013. 73: 6963-71
Paquet S, Fazli L, Grosse L, Verreault M, Tetu B, Rennie PS, Belanger A, Barbier O. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression. The Journal of clinical endocrinology and metabolism,  2012. 97: E428-32
Ekstrom L, Schulze JJ, Guillemette C, Belanger A, Rane A. Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene. Pharmacogenetics and genomics,  2011. 21: 325-32
Audet-Walsh E, Lepine J, Gregoire J, Plante M, Caron P, Tetu B, Ayotte P, Brisson J, Villeneuve L, Belanger A, Guillemette C. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. The Journal of clinical endocrinology and metabolism,  2011. 96: E330-9
© 2017 Tous droits réservés Centre de recherche du CHU de Québec